SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-24-000085
Filing Date
2024-08-06
Accepted
2024-08-06 06:57:57
Documents
86
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20240630.htm   iXBRL 10-Q 1717975
2 EX-31.1 anip-20240630x10qxexx311.htm EX-31.1 10312
3 EX-31.2 anip-20240630x10qxexx312.htm EX-31.2 9841
4 EX-32.1 anip-20240630x10qxexx321.htm EX-32.1 7024
  Complete submission text file 0001023024-24-000085.txt   9221740

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anip-20240630.xsd EX-101.SCH 56388
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anip-20240630_cal.xml EX-101.CAL 83530
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anip-20240630_def.xml EX-101.DEF 357857
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anip-20240630_lab.xml EX-101.LAB 784639
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anip-20240630_pre.xml EX-101.PRE 575513
89 EXTRACTED XBRL INSTANCE DOCUMENT anip-20240630_htm.xml XML 1312920
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 241177003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)